Latest News

September 19, 2011
Faculty are encouraged to apply for the T1 Translational Catalyst Award, which is designed to help drive promising, early-stage research through the lengthy and complex process of bringing products and procedures to patients.
July 18, 2011
Francis Collins, director of the National Institutes of Health (NIH), describes the scientific goals and functions of the National Center for Advancing Translational Sciences (NCATS), a proposed new entity of the NIH that will strive to reengineer the process of developing drugs, diagnostics, and devices. 
July 18, 2011
UCSF cognitive neuroscientist Adam Gazzaley has used functional brain imaging and EEG studies to discover that older adults fare worse than younger adults at remembering following distractions. He hopes to improve their performance with cognitive training, using a newly developed video game.
July 18, 2011
With renewed funding by the National Institutes of Health, the Clinical and Translational Science Institute at UCSF is poised to further accelerate the translation into clinical therapies, export its successes to other institutions and create initiatives to bring better health to more people more quickly. Explore this web package.
July 14, 2011
UCSF is the lead partner in the inaugural Bay Area Science Festival that will bring together an unprecedented brain trust of the region’s scientific and educational partners to produce what is expected to be one of the largest science-based events ever held in the United States.
July 10, 2011
UCSF's Clinical and Translational Science Institute (CTSI) has made several important contributions as it supports the University's advancing health worldwide mission.
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
May 05, 2011
UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
April 26, 2011
Scientists are making great strides in figuring out how the human brain develops, which are leading to novel ideas about the causes of a range of brain disorders, and are raising hopes for the regeneration of tissue that is lost in diseases such as Alzheimer’s. 
April 15, 2011
San Francisco Mayor Edwin M. Lee toured San Francisco General Hospital, where UCSF physicians and allied health care professionals provide patient care services, including the City's only level one trauma center.

Pages